Kenai Therapeutics
San Diego
About Kenai Therapeutics
Kenai Therapeutics focuses on developing therapies for neurodegenerative movement disorders. The company provides off-the-shelf neuron replacement medicines as effective disease-modifying treatments for neurological disorders, providing doctors with techniques to treat diseases like Parkinson's.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $97.0M
- Funding stage: Early Stage Venture
- Last round: Grant (Jan 2026)
- Website: kenaitx.com
- Phone: 815-505-6466
Industries & Categories
Biotechnology, Health Care, Medical, Neuroscience, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/kenai-therapeutics-43892 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.